Ongoing Clinical Trials

Clinical Trials Currently Recruiting Patients:

Dermatology Research Registry 

If you are interested in possibly participating in any of our current or future research studies, please sign up for our Dermatology Research Registry online at:    https://studypages.com/uncderm

 

Your information will be kept confidential and will only be used to contact you about potential research studies.  Your information will not be shared.

 

Adult Hidradenitis Suppurtiva (HS) Research Study (Injectable Medication)

Requirements: Adults (18-65 years) with moderate to severe hidradenitis suppurtiva (HS). Adults should be in general good health. Past use of some injectable medications for HS may preclude you from participating in the study.

Duration: One screening visit, one baseline visit, and 9 additional clinic visits at UNC Dermatology over the course of 24 weeks.


Incentive: Subjects are compensated for travel and parking costs. Study medication, study-related exams, and lab tests will be provided at no cost.


Sponsor: Supported by AbbVie Inc.


For more information please contact: Laura Keck    984-974-3682   lmcleod@email.unc.edu                                 

 

Molluscum Contagiosum Research Study

Requirements: Ages 2 years and older with active molluscum lesions. Participants should be in general good health. Investigator must consider all lesions safe to treat with investigational drug. Meet other eligibility criteria.


Duration: Up to 7 total clinic visits at UNC Dermatology and 11 phone call visits over the course of 84 days.


Incentive: Subject compensation available. Investigational study drug, and study-related exams will be provided at no cost.


Sponsor: Supported by Verrica Pharmaceuticals Inc.


For more information please contact: Laura Keck
                                                                 984-974-3682
                                                                 lmcleod@email.unc.edu

 

Pemphigus (Vulgaris or Foliaceus) Research Study (Infusion Medication)
Requirements: Patients (18+) with diagnosis of pemphigus (vulgaris or foliaceus) who have active disease.  Other requirements will be discussed with study staff.

 

Duration: Up to 18 total visits over the course of 18 weeks.
Incentive: Subject compensation available.  Study medication, study-related exams, and lab tests will be provided at no cost. 

 

 Sponsor: Supported by Syntimmune, Inc.

 

For more information please contact:    Laura Keck
                                                                    984-974-3682
                                                                 
   lmcleod@email.unc.edu


 Epidermolysis Bullosa Simplex (EBS) Research Study (Topical) Medication


Requirements: Patients (4+) with epidermolysis bullosa simplex. Additional treatments
other than the study medication are not permitted during the study period.

Duration: 8 total visits, 3 day to 6 week screening period, 8 week treatment period, plus a follow-up visit 4 weeks and 8 weeks after completing therapy.

Incentive: Subject compensation and travel assistance available. Study medication, study related exams, and lab tests will be provided at no cost.

Sponsor: Supported by Castle Creek Pharmaceuticals LLC


For more information please contact:

Laura Keck
984-974-3682
laura_mcleod@med.unc.edu


 

 

 

Your Physician:
Aida Lugo-Somolinos, MD
Link to Dr. Lugo-Somolinos' Research